Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Oct 15, 2020 6:46 AM ET

Autoimmune Disease Diagnostics Market Set to Attain $10,012.9 Million Valuation by 2030


Autoimmune Disease D

iCrowd Newswire - Oct 15, 2020

According to a report by P&S Intelligence, the global autoimmune disease diagnostics market is projected to generate a revenue of $10,012.9 million by 2030, and is predicted to progress at an 8.5% CAGR during the time period 2020–2030. The market is being driven by the increasing geriatric population, rising incidence of autoimmune diseases, growing initiatives taken by various government and private organizations for raising awareness regarding autoimmune diseases, discovery of biomarkers, and surging strategic developments among major players.

Request to view sample of this market research: https://www.psmarketresearch.com/market-analysis/autoimmune-disease-diagnostics-market-report/report-sample

On the basis of application, the autoimmune disease diagnostic market is divided into multiple sclerosis, rheumatoid arthritis (RA), systemic lupus erythematous, scleroderma, Sjogren’s syndrome, sarcoidosis, myasthenia gravis, and others. Out of all these, the RA division is projected to register the highest CAGR in the near future, which can be attributed to the rising awareness programs that are being organized by public and private organizations, growing cases of RA, and discovery of new biomarkers for the diagnosis of this diseases.

The objective of this research includes;

Geographically, North America is predicted to advance at the fastest pace in the coming years in the autoimmune disease diagnostics market. This can be owing to the widespread burden of autoimmune diseases, enhanced healthcare infrastructure, presence of established players, growing geriatric population, and rising research activities.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=autoimmune-disease-diagnostics-market-report

The major players operating in the autoimmune disease diagnostics market are Abbott Laboratories, Thermo Fisher Scientific Inc., bioMérieux S.A., Danaher Corporation, Siemens AG, Seramun Diagnostica GmbH, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Trinity Biotech plc, Exagen Inc., Cambridge Life Sciences Limited, , HYCOR Biomedical, Grifols S.A., ELITech Group, PerkinElmer Inc., Inova Diagnostics, Adaltis S.r.l., ORGENTEC Diagnostika GmbH, Bio-Rad Laboratories Inc., Sigma Diagnostics Inc., and A. Menarini Diagnostics S.r.l.

The research includes detailed analysis of;

Based on Product

Based on Test Type

Based on Application

Based on End User

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

International: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com



Contact Information:

enquiry@psmarketresearch.com








Tags:    Reportedtimes, Extended Distribution, iCN Internal Distribution, Research Newswire, English